Apolipoprotein e may be a critical factor in hormone therapy neuroprotection

Frontiers in Bioscience

Volumn 13, Issue 14, 2008, Pages 5387-5405

  Struble, Robert G ^a   Cady, Craig ^b   Nathan, Britto P ^c   McAsey, Mary ^a  

^a SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BRADLEY UNIVERSITY   (United States)

^c EASTERN ILLINOIS UNIVERSITY   (United States)

Author keywords

Apolipoprotein E; Hormone replacement; Menopause; Neuroprotection; Review

Indexed keywords

MUS;

APOLIPOPROTEIN E; HORMONE; NEUROPROTECTIVE AGENT;

ANIMAL; ANIMAL MODEL; CHRONIC DISEASE; DEMENTIA; ESTROGEN THERAPY; FEMALE; GENETICS; HUMAN; MENOPAUSE; MENSTRUAL CYCLE; MOUSE; MOUSE MUTANT; NEUROLOGIC DISEASE; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW; STROKE;

ANIMALS; APOLIPOPROTEINS E; CHRONIC DISEASE; DEMENTIA; ESTROGEN REPLACEMENT THERAPY; FEMALE; HORMONES; HUMANS; MENOPAUSE; MENSTRUAL CYCLE; MICE; MICE, KNOCKOUT; MODELS, ANIMAL; NERVOUS SYSTEM DISEASES; NEUROPROTECTIVE AGENTS; STROKE;

EID: 52049120567     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: 10.2741/3088     Document Type: Review

References (223)

1. Rossouw J. E, G. L. Anderson, R. L. Prentice, A. Z. LaCroix, C. Kooperberg, M. L. Stefanick, R. D. Jackson, S. A. Beresford, B. V. Howard, K. C. Johnson, J. M. Kotchen, J. Ockene: Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA 288, 321-333 (2002) (Pubitemid 34761611)
2. Saitoh M, , M. Ohmichi, K. Takahashi, J. Kawagoe, T. Ohta, M. Doshida, T. Takahashi, H. Igarashi, A. Mori-Abe, B. Du, S. Tsutsumi, H. Kurachi: Medroxyprogesterone acetate induces cell proliferation through up-regulation of cyclin D1 expression via phosphatidylinositol 3-kinase/Akt/nuclear factor-kappaB cascade in human breast cancer cells. Endocrinology 146, 4917-4925 (2005) (Pubitemid 41446630)
3. Seeger H, D. Wallwiener, A. O. Mueck: The effect of progesterone and synthetic progestins on serum-and estradiol-stimulated proliferation of human breast cancer cells. Horm Metab Res 35, 76-80 (2003) (Pubitemid 36583677)
4. Vickers M. R, A. H. MacLennan, B. Lawton, D. Ford, J. Martin, S. K. Meredith, B. L. DeStavola, S. Rose, A. Dowell, H. C. Wilkes, J. H. Darbyshire, T. W. Meade, WISDOM group: Main morbidities recorded in the women's international study of long duration oestrogen after menopause (WISDOM): a randomised controlled trial of hormone replacement therapy in postmenopausal women. BMJ 335, 239-251 (2007)
5. Haas J. S, C. P. Kaplan, E. P. Gerstenberger, K. Kerlikowske: Changes in the use of postmenopausal hormone therapy after the publication of clinical trial results. Ann Intern Med 140, 184-188 (2004)
6. Hersh A. L, M. L. Stefanick, R. S. Stafford: National use of postmenopausal hormone therapy: annual trends and response to recent evidence. JAMA 291, 47-53 (2004) (Pubitemid 38040534)
7. Bennett D. A, J. A. Schneider, Z. Arvanitakis, J. F. Kelly N. T. Aggarwal, R. C. Shah, R. S. Wilson: Neuropathology of older persons without cognitive impairment from two community-based studies. Neurology 66, 1837-1844 (2006) (Pubitemid 44049813)
8. S. G. Gabbe, J. R. Niebyl, J. L. Simpson, (eds) Obstetrics: normal and problem pregnancies. 5th ed, Churchill Livingstone/Elsevier, Philadelphia, PA, 2007.
9. M. A. Stenchever. Comprehensive gynecology. 4th ed., Mosby, St. Louis, MO, 2001.
10. P. Reed H. Larsen, M. Kronenbery, S. Melmed, K. S. Polonsky (eds.) Williams textbook of endocrinology, 10th ed., Saunders, Philadelphia, PA. 2002.
11. J. D. Neill. (ed.) Knobil and Neill's Physiology of Reproduction, 3rd ed., Elsevier, Boston, MA, 2006.
12. Kawas C, S. Resnick, A. Morrison, R. Brookmeyer, M. Corrada, A. Zonderman, C. Bacal, D. D. Lingle, E. Metter: A prospective study of estrogen replacement therapy and the risk of developing Alzheimer's disease: the Baltimore Longitudinal Study of Aging. Neurology 48, 1517-1521 (1997)
13. Paganini-Hill A, V. Henderson: Estrogen deficiency and risk of Alzheimer's disease in women. Am J Epidemiol 140, 256-261 (1994) (Pubitemid 24231911)
14. Brenner D. E, W. A. Kukull, A. Stergachis, G. van Belle, J. D. Bowen, W. C. McCormick, L. Teri, E. B. Larson: Postmenopausal estrogen replacement therapy and the risk of Alzheimer's disease: a population-based casecontrol study. Am J Epidemiol 140, 262-267 (1994) (Pubitemid 24231912)
15. Tang M. X, D. Jacobs, Y. Stern, K. Marder, P. Schofield, B. Gurland, H. Andrews, R. Mayeux: Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease. Lancet 348, 429-432 (1996) (Pubitemid 26267873)
16. LeBlanc E. S, J. Janowsky, B. K. Chan, H. D. Nelson: Hormone replacement therapy and cognition: systematic review and meta-analysis. JAMA 285, 1489-1499 (2001) (Pubitemid 32221898)
17. Zandi P. P, M. C. Carlson, B. L. Plassman, K. A. Welsh-Bohmer, L. S. Mayer, D. C. Steffens, J. C. Breitner: Hormone replacement therapy and incidence of Alzheimer disease in older women: the Cache County Study. JAMA 288, 2123-2129 (2002) (Pubitemid 35265379)
18. Henderson V. W, K. S. Benke, R. C. Green, L. A. Cupples, L. A. Farrer, MIRAGE Study Group: Postmenopausal hormone therapy and Alzheimer's disease risk: interaction with age. J Neurol Neurosurg Psychiat 76, 103-105 (2005) (Pubitemid 40013499)
19. Rocca W. A, J. H. Bower, D. M. Maraganore, J. E. Ahlskog, B. R. Grossardt, M. de Andrade, and L. J. Melton III: Increased risk of cognitive impairment or dementia in women who underwent oophorectomy before menopause Neurology 69, 1074-1083 (2007) (Pubitemid 47517552)
20. Mulnard R. A, C. W. Cotman, C. Kawas, C. H. van Dyck, M. Sano, R. Doody, E. Koss, E. Pfeiffer, S. Jin, A. Gamst, M. Grundman, R. Thomas, L. J. Thal: Estrogen replacement therapy for treatment of mild to moderate Alzheimer disease: a randomized controlled trial. Alzheimer's Disease Cooperative Study. JAMA 283, 1007-1015 (2000) (Pubitemid 30112214)
21. Wang P. N, S. Q. Liao, R. S. Liu, C. Y. Liu, H. T. Chao, S. R. Lu, H. Y. Yu, S. J. Wang, H. C. Liu: Effects of estrogen on cognition, mood, and cerebral blood flow in AD: a controlled study. Neurology 54, 2061-2066 (2000) (Pubitemid 30397202)
22. Henderson V. W, A. Paganini-Hill, B. L. Miller, R. J. Elble, P. F. Reyes, D. Shoupe, C. A. McCleary, R. A. Klein, A. M. Hake, M. R. Farlow: Estrogen for Alzheimer's disease in women: randomized, double-blind, placebo-controlled trial. Neurology 54, 295-301 (2000) (Pubitemid 30078056)
23. Thal L. J, R. G. Thomas, R. Mulnard, M. Sano, M. Grundman, L. Schneider. Estrogen levels do not correlate with improvement in cognition. Arch Neurol 60, 209-212 (2003) (Pubitemid 36193964)
24. Asthana S, L. D. Baker, S. Craft, F. Z. Stanczyk, R. C. Veith, M. A. Rasking, S. R. Plymate. High-dose estradiol improves cognition for women with AD: results of a randomized study. Neurology 57, 605-612 (2001) (Pubitemid 32782986)
25. Espeland M. A, S. R. Rapp, S. A. Shumaker, R. Brunner, J. E. Manson, B. B. Sherwin, J. Hsia, K. L. Margolis, P. E. Hogan, R. Wallace, M. Dailey, R. Freeman, J. Hays: Women's Initiative Memory Study. Conjugated equine estrogens and global cognitive function in postmenopausal women: Women's Health Initiative Memory Study. JAMA 291, 2959-2968 (2004) (Pubitemid 38802685)
26. Shumaker S, A, C. Legault, L. Kuller, S. R. Rapp, L. Thal, D. S. Lane, H. Fillit, M. L. Stefanick, S. L. Hendrix, C. E. Lewis, K. Masaki, L. H. Coker: Women's Health Initiative Memory Study. Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women's Health Initiative Memory Study. JAMA 291, 2947-2958 (2004). (Pubitemid 38802684)
27. Paganini-Hill A: Estrogen replacement therapy and stroke. Prog Cardiovasc Dis 38, 223-242 (1995)
28. Stein D. G.: Brain damage, sex hormones and recovery: a new role for progesterone and estrogen? Trends Neurosci 24, 386-91 (2001) (Pubitemid 32938541)
29. Paganini-Hill A, M. Perez Barreto: Stroke risk in older men and women: aspirin, estrogen, exercise, vitamins, and other factors. J Gend Specif Med 4, 18-28 (2001) (Pubitemid 34023959)
30. Simpkins J. W, S. H. Yang, Y. Wen, M. Singh: Estrogens, progestins, menopause and neurodegeneration: basic and clinical studies. Cell Mol Life Sci 62, 271-280 (2005) (Pubitemid 40379242)
31. Snowdon D. A, L. H. Greiner, J. A. Mortimer, K. P. Riley, P. A. Greiner, W. R. Markesbery: Brain infarction and the clinical expression of Alzheimer disease. The Nun Study JAMA 277, 813-817 (1997) (Pubitemid 27111317)
32. Saunders-Pullman R, J. Gordon-Elliott, M. Parides, S. Fahn, H. R. Saunders, S. Bressman: The effect of estrogen replacement on early Parkinson's disease. Neurology 52, 1417-1421 (1999) (Pubitemid 29190534)
33. Currie L. J, M. B. Harrison, J. M. Trugman, J. P. Bennett, G. F. Wooten. Postmenopausal estrogen use affects risk for Parkinson disease. Arch Neurol 61, 886-888 (2004) (Pubitemid 38747327)
34. Rocca W. A, J. H. Bower, D. M. Maraganore, J. E. Ahlskog, B. R. Grossardt, M. de Andrade, and L. J. Melton III: Increased risk of parkinsonism in women who underwent oophorectomy before menopause. Neurology 64, 1458-1464. (2007)
35. Smith R, J. W. Studd: A pilot study of the effect upon multiple sclerosis of the menopause, hormone replacement therapy and the menstrual cycle. J R Soc Med 85, 612-613 (1992)
36. Holmqvist P, , M. Wallberg, M. Hammar, A. M. Landtblom, J. Brynhildsen: Symptoms of multiple sclerosis in women in relation to sex steroid exposure. Maturitas 54, 149-153 (2006) (Pubitemid 44294287)
37. Voskuhl R. R: Hormone-based therapies in MS. Int MS J 10, 60-66 (2003) (Pubitemid 36717792)
38. Sicotte N. L, S. M. Liva, R. Klutch, P. Pfeiffer, S. Bouvier, S. Odesa, T. C. Wu, R. R. Voskuhl: Treatment of multiple sclerosis with the pregnancy hormone estriol. Ann Neurol 52, 421-428. (2002)
39. Houtchens M. K, : Pregnancy and multiple sclerosis. Semin Neurol 27, 434-441. (2007) (Pubitemid 350022487)
40. Mahley R. W: Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science 240, 622-630 (1988)
41. Boyles J. K, C. D. Zoellner, L. J. Anderson, L. M. Kosik, R. E. Pitas, K. H. Weisgraber, D. Y. Hui, R. W. Mahley, P. J. Gebicke-Haerter, M, J. Ignatius: A role for apolipoprotein E, apolipoprotein A-I, and low density lipoprotein receptors in cholesterol transport during regeneration and remyelination of the rat sciatic nerve. J Clin Invest 83, 1015-1031 (1989) (Pubitemid 19080637)
42. Menzel H. J, G. Assmann, S. C. Rall Jr., K. H. Weisgraber R. W. Mahley: Human apolipoprotein A-I polymorphism. Identification of amino acid substitutions in three electrophoretic variants of the Munster-3 type, J Biol Chem 259, 3070-3076 (1984) (Pubitemid 14162546)
43. Hallman D. M, E. Boerwinkle, N. Saha, C. Sandholzer, H. J. Menzel, A. Csazar, G. Utermann: The apolipoprotein E polymorphism: a comparison of allele frequencies and effects in nine populations, Am J Hum Genet 49, 338-349 (1991) (Pubitemid 21891679)
44. Weisgraber K. H: Apolipoprotein E: structure-function relationships. Adv Protein Chem 45, 249-302 (1994) (Pubitemid 24139890)
45. Davignon J, R. E. Gregg, C. F. Sing: Apolipoprotein E polymorphism and atherosclerosis, Arteriosclerosis 8, 1-21 (1988) (Pubitemid 18049171)
46. Herz J, D. K. Strickland: LRP: a multifunctional scavenger and signaling receptor. J Clin Invest 108, 779-784 (2001) (Pubitemid 32880284)
47. Herz J, H. H. Bock: Lipoprotein receptors in the nervous system. Ann Rev Biochem 71, 405-434 (2002) (Pubitemid 34800226)
48. Strickland D. K, S. Ranganathan: Diverse role of LDL receptor-related protein in the clearance of proteases and in signaling. J Thromb Haemost 1, 1663-1670 (2003)
49. Srivastava R. A, N. Bhasin, N. Srivastava: Apolipoprotein E gene expression in various tissues of mouse and regulation by estrogen Biochem Mol Biol Int 38, 91-101 (1996) (Pubitemid 26340465)
50. Levin-Allerhand J, B. S. McEwen, C. E. Lominska, D. B. Lubahn, K. S. Korach, J. D. Smith: Brain region-specific up-regulation of mouse apolipoprotein E by pharmacological estrogen treatments. J Neurochem 79, 796-803 (2001) (Pubitemid 33086517)
51. Struble R. G, E. R. Rosario, M. L. Kircher, S. M. Ludwig, P. J. McAdamis, K. Watabe, M. E. McAsey, C. Cady, B. P. Nathan: Regionally specific modulation of brain apolipoprotein E in the mouse during the estrous cycle and by exogenous 17β estradiol. Exp Neurol 183, 638-44 (2003) (Pubitemid 37205106)
52. McAsey M. E, C. Cady, L. M. Jackson, M. Li, S. Randall, B. P. Nathan, R. G. Struble: Time course of response to estradiol replacement in ovariectomized mice: brain apolipoprotein E and synaptophysin transiently increase and glial fibrillary acidic protein is suppressed. Exp Neurol 197, 197-205 (2006) (Pubitemid 41817233)
53. Cheng X, M. E. McAsey, M. Li, S. Randall, C. Cady, B. P. Nathan, R. G. Struble: Estradiol replacement increases the low-density lipoprotein receptor related protein (LRP) in the mouse brain. Neurosci Lett 417, 50-54 (2007) (Pubitemid 46517838)
54. Saunders A. M, K. Schmader, J. C. Breitner, M. D. Benson, W. T. Brown, L. Goldfarb, D. Goldgaber, M. G. Manwaring, M. H. Szymanski, N. McCown: Apolipoprotein E epsilon 4 allele distributions in late-onset Alzheimer's disease and in other amyloid-forming diseases. Lancet 342, 710-711 (1993) (Pubitemid 23279765)
55. Gopalraj R. K, H. Zhu, J. F. Kelly, M. Mendiondo, J. F. Pulliam, D. A. Bennett, S. Estus: Genetic association of low density lipoprotein receptor and Alzheimer's disease. Neurobiol Aging 26, 1-7 (2005) (Pubitemid 39600585)
56. Kolsch H, U. Ptok, I. Mohamed, S. Schmitz, M. L. Rao, W. Maier, R. Heun: Association of the C766T polymorphism of the low-density lipoprotein receptorrelated protein gene with Alzheimer's disease. Am J Med Genet B Neuropsychiatr Genet 121, 128-130 (2003) (Pubitemid 37064042)
57. Holtzman D. M: In vivo effects of ApoE and clusterin on amyloid-beta metabolism and neuropathology. J Mol Neurosci 23, 247-254 (2004)
58. Bu G, J. Cam, C. Zerbinatti: LRP in amyloid-beta production and metabolism. Ann N Y Acad Sci. 1086, 35-53 (2006)
59. Tang G, H. Xie, L. Xu, Y. Hao, D. Lin, D. Ren: Genetic study of apolipoprotein E gene, alpha-1 antichymotrypsin gene in sporadic Parkinson disease. Am J Med Genet 114, 446-449 (2002) (Pubitemid 34525244)
60. Zareparsi S, R. Camicioli, G. Sexton, T. Bird, P. Swanson, J. Kaye, J. Nutt, H. Payami: Age at onset of Parkinson disease and apolipoprotein E genotypes. Am J Med Genet 107, 156-161 (2002) (Pubitemid 34038598)
61. Buchanan D. D, P. A. Silburn, J. A. Prince, G. D. Mellick: Association of APOE with Parkinson disease ageat-onset in women. Neurosci Lett 411, 185-188 (2007) (Pubitemid 44828271)
62. Ghebremedhin E, K. Del Tredici, M. Vuksic, U. Rub, D.R. Thal, G. J. Burbach, A. Rosenberger, H. Bickeboller, T. Deller, R. A. de Vos, E. N. Jansen Steur, H. Braak: Relationship of apolipoprotein E and age at onset to Parkinson disease neuropathology. J Neuropathol Exp Neurol 65, 116-123 (2006)
63. Huang X, P. Chen, D. I. Kaufer, A. I. Troster, C. Poole: Apolipoprotein E and dementia in Parkinson disease: a meta-analysis. Arch Neurol 63, 189-193 (2006) (Pubitemid 43261729)
64. Short R. A, N. R. Graff-Radford, J. Adamson, M. Baker, M. Hutton: Differences in tau and apolipoprotein E polymorphism frequencies in sporadic frontotemporal lobar degeneration syndromes. Arch Neurol 59, 611-615 (2002) (Pubitemid 34289965)
65. Jordan B. D, N. R. Relkin, L. D. Ravdin, A. R. Jacobs, , A. Bennett, S. Gandy: Apolipoprotein E epsilon4 associated with chronic traumatic brain injury in boxing. JAMA 278, 136-140 (1997) (Pubitemid 27287671)
66. Friedman G, P. Froom, L. Sazbon, I. Grinblatt, M. Shochina, J. Tsenter, S. Babaey, Z. Yehuda Groswasser: Apolipoprotein E-epsilon4 genotype predicts a poor outcome in survivors of traumatic brain injury. Neurology 52, 244-248 (1999) (Pubitemid 29059046)
67. Masterman T, Z. Zhang, D. Hellgren, H. Salter, M. Anvret, L. Lilius, L. Lannfelt, J. Hillert: APOE genotypes and disease severity in multiple sclerosis. Mult Scler 8, 98-103 (2002) (Pubitemid 34256744)
68. Fazekas F, S. Strasser-Fuchs, H. Kollegger, T. Berger, W. Kristoferitsch, C. Schmidt, H. Enzinger, M. Schiefermeier, C. Schwarz, B. Kornek, M. Reindl, K. Huber, R. Grass, G. Wimmer, K. Vass, K. H. Pfeiffer, H. P. Hartung, R. Schmidt: Apolipoprotein E epsilon 4 is associated with rapid progression of multiple sclerosis. Neurology 57, 853-857 (2001) (Pubitemid 32845507)
69. Li Y. J, M. A. Pericak-Vance, J. L. Haines, N. Siddique, D. McKenna-Yasek, W. Y. Hung, P. Sapp, C. I. Allen, W. Chen, B. Hosler, A, M. Saunders, L. M. Dellefave, R. H. Brown, T. Siddique: Apolipoprotein E is associated with age at onset of amyotrophic lateral sclerosis. Neurogenetics 5, 209-213 (2004) (Pubitemid 40174640)
70. Drory V. E, M. Birnbaum, A. D. Korczyn, J. Chapman: Association of APOE epsilon4 allele with survival in amyotrophic lateral sclerosis. J Neurol Sci 190, 17-20 (2001) (Pubitemid 33713016)
71. Briellmann R. S, Y. Torn-Broers, B. E. Busuttil, B. J. Major, R. M. Kalnins, M. Olsen, G. D. Jackson, A. G. Frauman, S. F. Berkovic: APOE epsilon4 genotype is associated with an earlier onset of chronic temporal lobe epilepsy. Neurology 55, 435-437 (2000) (Pubitemid 30650088)
72. Sporis D, J. Sertic, N. Henigsberg, D. Mahovic, N. Bogdanovic, T. Babic. Association of refractory complex partial seizures with a polymorphism of ApoE genotype. J Cell Mol Med 9, 698-703 (2005) (Pubitemid 44151957)
73. Diaz-Arrastia R, Y. Gong, S. Fair, K. D. Scott, M. C. Garcia, M. C. Carlile, M. A. Agostini, P. C. Van Ness: Increased risk of late posttraumatic seizures associated with inheritance of APOE epsilon4 allele Arch Neurol 60, 818-22 (2003) (Pubitemid 36705967)
74. Yaffe K, M. Haan, A. Byers, C. Tangen, L. Kuller: Estrogen use, APOE, and cognitive decline: evidence of gene-environment interaction. Neurology 54, 1949-1954 (2000)
75. Burkhardt M. S, J. K. Foster, S. M. Laws, L. D. Baker, S. Craft, S. E. Gandy, B. G. Stuckey, R. Clarnette, D. Nolan, B. Hewson-Bower, R. N. Martins: Oestrogen replacement therapy may improve memory functioning in the absence of APOE epsilon4. J Alzheimers Dis 6, 221-228 (2004) (Pubitemid 38823256)
76. Rippon G. A, M. X. Tang, J. H. Lee, R. Lantigua, M. Medrano, R. Mayeux: Familial Alzheimer disease in Latinos: interaction between APOE, stroke, and estrogen replacement. Neurology 66, 35-40 (2006) (Pubitemid 43739588)
77. Mattila K. M, K. Axelman, J. O. Rinne, M. Blomberg, T. Lehtimaki, P. Laippala, M. Roytta, M. Viitanen, L. Wahlund, B. Winblad, L. Lannfelt: Interaction between estrogen receptor 1 and the epsilon 4 allele of apolipoprotein E increases the risk of familial Alzheimer's disease in women. Neurosci Lett 282, 45-8 (2000) (Pubitemid 30129165)
78. Liu R, X. Wang, Q. Liu, S. H. Yang, J. W. Simpkins: Dose dependence and therapeutic window for the neuroprotective effects of 17beta-estradiol when administered after cerebral ischemia. Neurosci Lett 415, 237-241 (2007) (Pubitemid 46400270)
79. Simpkins J. W, G. Rajakumar, Y. Q. Zhang, C. E. Simpkins, D. Greenwald, C. J. Yu, N. Bodor, A. L. Day: Estrogens may reduce mortality and ischemic damage caused by middle cerebral artery occlusion in the female rat. J Neurosurg 87, 724-730 (1997) (Pubitemid 27454591)
80. Zhang Y. Q, J. Shi, G. Rajakumar, A. L. Day, J. W. Simpkins: Effects of gender and estradiol treatment on focal brain ischemia. Brain Res 784, 321-324 (1998) (Pubitemid 28137875)
81. Hall E. D, K. E. Pazara, K. L. Linseman: Sex differences in postischemic neuronal necrosis in gerbils. J Cereb Blood Flow Metab 11, 292-298 (1991)
82. Shi J, Y. Q. Zhang, J. W. Simpkins: Effects of 17betaestradiol on glucose transporter 1 expression and endothelial cell survival following focal ischemia in the rats. Exp Brain Res 117, 200-206 (1997) (Pubitemid 27488781)
83. Dubal D. B, M. L. Kashon, L. C. Pettigrew, J. M. Ren, S. P. Finklestein, S. W. Rau, P. M. Wise: Estradiol protects against ischemic injury. J Cereb Blood Flow Metab 18, 1253-1258 (1998) (Pubitemid 28509840)
84. Toung T. J, R. J. Traystman, P. D. Hurn: Estrogenmediated neuroprotection after experimental stroke in male rats. Stroke 29, 1666-1670 (1998) (Pubitemid 28365591)
85. Rusa R, N. J. Alkayed, B. J. Crain, R. J. Traystman, A. S. Kimes, E. D. London, J. A. Klaus, P. D. Hurn: 17betaestradiol reduces stroke injury in estrogen-deficient female animals. Stroke 30, 1665-1670 (1999) (Pubitemid 29379621)
86. Alkayed N. J, S. J. Murphy, R. J. Traystman, P. D. Hurn, V. M. Miller: Neuroprotective effects of female gonadal steroids in reproductively senescent female rats. Stroke 31, 161-168 (2000) (Pubitemid 30035770)
87. Fukuda K, H. Yao, S. Ibayashi, T. Nakahara, H. Uchimura, M. Fujishima, E. D. Hall: Ovariectomy exacerbates and estrogen replacement attenuates photothrombotic focal ischemic brain injury in rats. Stroke 31, 155-160 (2000) (Pubitemid 30035769)
88. Veliskova J, L. Velisek, A. S. Galanopoulou, E. F. Sperber: Neuroprotective effects of estrogens on hippocampal cells in adult female rats after status epilepticus. Epilepsia 41, Suppl 6:S30-35 (2000)
89. Dubal D. B, P. M. Wise: Neuroprotective effects of estradiol in middle-aged female rats. Endocrinology 142, 43-48 (2001) (Pubitemid 32183664)
90. Harukuni I, P. D. Hurn, B. J. Crain: Deleterious effect of beta-estradiol in a rat model of transient forebrain ischemia. Brain Res 900, 137-142 (2001) (Pubitemid 32452273)
91. Watanabe Y, M. T. Littleton-Kearney, R. J. Traystman, P. D. Hurn: Estrogen restores postischemic pial microvascular dilation. Am J Physiol Heart Circ Physiol 281, H155-160 (2001)
92. Santizo R. A, H. L. Xu, S. Ye, V. L. Baughman, D. A. Pelligrino: Loss of benefit from estrogen replacement therapy in diabetic ovariectomized female rats subjected to transient forebrain ischemia. Brain Res 956, 86-95 (2002) (Pubitemid 35335560)
93. He Z, Y. J. He, A. L. Day, J. W. Simpkins: Proestrus levels of estradiol during transient global cerebral ischemia improves the histological outcome of the hippocampal CA1 region: perfusion-dependent and-independent mechanisms. J Neurol Sci 193, 79-87 (2002) (Pubitemid 34098938)
94. Mehta S. H, K. M. Dhandapani, L. M. De Sevilla, R. C. Webb, V. B. Mahesh, D. W. Brann: Tamoxifen, a selective estrogen receptor modulator, reduces ischemic damage caused by middle cerebral artery occlusion in the ovariectomized female rat. Neuroendocrinology 77, 44-50 (2003) (Pubitemid 36302421)
95. Fan T, S.H. Yang, E. Johnson, B. Osteen, R. Hayes, A. L. Day, J. W. Simpkins: 17beta-Estradiol extends ischemic thresholds and exerts neuroprotective effects in cerebral subcortex against transient focal cerebral ischemia in rats. Brain Res 993, 10-17 (2003) (Pubitemid 37464578)
96. Shughrue P. J, I. Merchenthaler: Estrogen prevents the loss of CA1 hippocampal neurons in gerbils after ischemic injury. Neuroscience 116, 851-861 (2003) (Pubitemid 36160578)
97. Wen Y, S. Yang, R. Liu, E. Perez, K. D. Yi, P. Koulen, J. W. Simpkins: Estrogen attenuates nuclear factor-kappa B activation induced by transient cerebral ischemia. Brain Res 1008, 147-154 (2004) (Pubitemid 38624044)
98. Xu H. L, V. L. Baughman, D. A. Pelligrino: Estrogen replacement treatment in diabetic ovariectomized female rats potentiates postischemic leukocyte adhesion in cerebral venules. Stroke 35, 1974-1978 (2004) (Pubitemid 38971886)
99. Carswell H. V, D. Bingham, K. Wallace, M. Nilsen, D. I. Graham, A. F. Dominiczak, I. M. Macrae: Differential effects of 17beta-estradiol upon stroke damage in stroke prone and normotensive rats. J Cereb Blood Flow Metab 24, 298-304 (2004) (Pubitemid 38324529)
100. Chaovipoch P, K. A. Jelks, L. M. Gerhold, E. J. West, S. Chongthammakun, C. L. Floyd: 17beta-estradiol is protective in spinal cord injury in post-and pre-menopausal rats. J Neurotrauma 23, 830-852 (2006) (Pubitemid 43962845)
101. Wise P. M.: Estrogen therapy: does it help or hurt the adult and aging brain? Insights derived from animal models. Neuroscience 138, 831-835 (2006)
102. Sandstrom N. J, M. H. Rowan: Acute pretreatment with estradiol protects against CA1 cell loss and spatial learning impairments resulting from transient global ischemia. Horm Behav. 51, 335-345 (2007) (Pubitemid 46365685)
103. Wise P. M, D.B. Dubal: Estradiol protects against ischemic brain injury in middle-aged rats. Biol Reprod 63, 982-985 (2000)
104. Wang Q, R. Santizo, V. L. Baughman, D. A. Pelligrino, C. Iadecola: Estrogen provides neuroprotection in transient forebrain ischemia through perfusionindependent mechanisms in rats. Stroke 30, 630-637 (1999) (Pubitemid 29115403)
105. Chi O. Z, X. Liu, H. R. Weiss: Effects of 17betaestradiol on blood-brain barrier disruption during focal ischemia in rats. Horm Metab Res 34, 530-534. (2002) (Pubitemid 35192241)
106. Bingham D, I. M. Macrae, H. V. Carswell. Detrimental effects of 17beta-oestradiol after permanent middle cerebral artery occlusion. J Cereb Blood Flow Metab 25, 414-420 (2005) (Pubitemid 40315883)
107. Gordon K. B, I. M. Macrae, V. Carswell: Effects of 17beta-oestradiol on cerebral ischaemic damage and lipid peroxidation. Brain Res 1036, 155-162 (2005) (Pubitemid 40255855)
108. Theodorsson A, E .Theodorsson: Estradiol increases brain lesions in the cortex and lateral striatum after transient occlusion of the middle cerebral artery in rats: no effect of ischemia on galanin in the stroke area but decreased levels in the hippocampus. Peptides 26, 2257-2264 (2005) (Pubitemid 41584093)
109. Yong Y, H. J. Xie, Y. F. Zhang, Q. D. Yang, D. F. Liao, H. L. Yang, P. K. Yan, Z. J. Liu: 17beta-estradiol potentiates ischemia-reperfusion injury in diabetic ovariectomized female rats. Brain Res 1054, 192-199 (2005) (Pubitemid 41219349)
110. Gulinello M, D. Lebesgue, T. Jover-Mengual, R. S. Zukin, A. M. Etgen: Acute and chronic estradiol treatments reduce memory deficits induced by transient global ischemia in female rats. Horm Behav 49, 246-260 (2006) (Pubitemid 43152499)
111. Suzuki S, C. M. Brown, C. D. De la Cruz, E. Yang, D. A. Bridwell, P. M. Wise: Timing of estrogen therapy after ovariectomy dictates the efficacy of its neuroprotective and anti-inflammatory actions. Proc Natl Acad Sci U S A 104, 6013-6018 (2007) (Pubitemid 47175650)
112. Won C. K, H. H. Ji, P. O. Koh: Estradiol prevents the focal cerebral ischemic injury-induced decrease of forkhead transcription factors phosphorylation. Neurosci Lett 398, 39-43 (2006)
113. Chi O. Z, C. Hunter, X. Liu, H.R. Weiss: Effects of 17beta-estradiol on blood-brain barrier disruption during focal cerebral ischemia in younger and older rats. Horm Metab Res 38, 377-381 (2006) (Pubitemid 44047959)
114. Horsburgh K, I. M. Macrae, H. Carswell: Estrogen is neuroprotective via an apolipoprotein E-dependent mechanism in a mouse model of global ischemia. J Cereb Blood Flow Metab 22, 1189-1195 (2002)
115. Qiu Z, K. A. Crutcher, B. T. Hyman, G. W. Rebeck: ApoE isoforms affect neuronal N-methyl-D-aspartate calcium responses and toxicity via receptor-mediated processes. Neuroscience 122, 291-303 (2003) (Pubitemid 37410161)
116. Yepes M, D. A. Lawrence: Neuroserpin: a selective inhibitor of tissue-type plasminogen activator in the central nervous system. Thromb Haemost 91, 457-464 (2004) (Pubitemid 38396867)
117. Biehle S. J, J. Carrozzella, R. Shukla, J. Popplewell, M. Swann, N. Freeman, J. F. Clark: Apolipoprotein E isoprotein-specific interactions with tissue plasminogen activator. Biochim Biophys Acta 1689, 244-251 (2004) (Pubitemid 38986958)
118. Benchenane K, V. Berezowski, C. Ali, M. Fernandez-Monreal, J. P. Lopez-Atalaya, J. Brillault, J. Chuquet, A. Nouvelot, E. T. MacKenzie, G. Bu, R. Cecchelli, O. Touzani, D. Vivien: Tissue-type plasminogen activator crosses the intact blood-brain barrier by low-density lipoprotein receptor-related protein-mediated transcytosis. Circulation 111, 2241-2249 (2005) (Pubitemid 40632441)
119. Gould E, C. S. Woolley, M. Frankfurt, B. S. McEwen: Gonadal steroids regulate dendritic spine density in hippocampal pyramidal cells in adulthood. J Neurosci 10, 1286-1291 (1990)
120. Woolley C. S, B. S. McEwen: Estradiol mediates fluctuation in hippocampal synapse density during the estrous cycle in the adult rat. J Neurosci 12, 2549-2554 (1992)
121. Thiele C, M. J. Hannah, F. Fahrenholz, W. B. Huttner: Cholesterol binds to synaptophysin and is required for biogenesis of synaptic vesicles. Nat Cell Biol 2, 42-49. (2000)
122. Brake W. G. S. E. Alves, J. C. Dunlop, S. J. Lee, K. Bulloch, P. B. Allen, P. Greengard, B. S. McEwen: Novel target sites for estrogen action in the dorsal hippocampus: an examination of synaptic proteins. Endocrinology 142, 1284-1289 (2001) (Pubitemid 32202840)
123. Stone D. J, I. Rozovsky, T. E. Morgan, C. P. Anderson, C. E. Finch: Increased synaptic sprouting in response to estrogen via an apolipoprotein E-dependent mechanism: implications for Alzheimer's disease. J Neurosci 18, 3180-3185 (1998) (Pubitemid 28186010)
124. Gibbs R. B, D. Wu, L. B. Hersh, D. W. Pfaff: Effects of estrogen replacement on the relative levels of choline acetyltransferase, trkA, and nerve growth factor messenger RNAs in the basal forebrain and hippocampal formation of adult rats. Exp Neurol 129, 70-80 (1994) (Pubitemid 24344158)
125. Gibbs R. B: Fluctuations in relative levels of choline acetyltransferase mRNA in different regions of the rat basal forebrain across the estrous cycle: effects of estrogen and progesterone. J Neurosci 16, 1049-1055 (1996) (Pubitemid 26140861)
126. Luine V. N: Estradiol increases choline acetyltransferase activity in specific basal forebrain nuclei and projection areas of female rats. Exp Neurol 89, 484-490 (1985) (Pubitemid 15040918)
127. Kaufman H, C. Vadasz, A. Lajtha: Effects of estradiol and dexamethasone on choline acetyltransferase activity in various rat brain regions. Brain Res 453, 389-392 (1988)
128. Lapchak P. A, D. M. Araujo, R. Quirion, A. Beaudet: Chronic estradiol treatment alters central cholinergic function in the female rat: effect on choline acetyltransferase activity, acetylcholine content, and nicotinic autoreceptor function. Brain Res 525, 249-255 (1990) (Pubitemid 20257743)
129. Singh M, E. M. Meyer, W. J. Millard, J. W. Simpkins: Ovarian steroid deprivation results in a reversible learning impairment and compromised cholinergic function in female Sprague-Dawley rats. Brain Res 644, 305-312 (1994) (Pubitemid 24127987)
130. Singh M, E. M. Meyer, J. W. Simpkins: The effect of ovariectomy and estradiol replacement on brainderived neurotrophic factor messenger ribonucleic acid expression in cortical and hippocampal brain regions of female Sprague-Dawley rats. Endocrinology 136, 2320-2324 (1995)
131. Gibbs R. B: Effects of estrogen on basal forebrain cholinergic neurons vary as a function of dose and duration of treatment. Brain Res 757, 10-16 (1997) (Pubitemid 27244615)
132. Gibbs R. B, R. Gabor: Estrogen and cognition: applying preclinical findings to clinical perspectives. J Neurosci Res 74, 637-643 (2003) (Pubitemid 37475444)
133. Islamov R. R, W. A. Hendricks, R. J. Jones, G. J. Lyall, N. S. Spanier, A. K. Murashov: 17Beta-estradiol stimulates regeneration of sciatic nerve in female mice. Brain Res 943, 283-286. (2002) (Pubitemid 36120387)
134. Kadish I, T. J. Van Groen: Low levels of estrogen significantly diminish axonal sprouting after entorhinal cortex lesions in the mouse. Neurosci 22, 4095-4102 (2002) (Pubitemid 37465717)
135. Morse J. K, S. W. Scheff, S. T. DeKosky: Gonadal steroids influence axon sprouting in the hippocampal dentate gyrus: a sexually dimorphic response. Exp Neurol 94, 649-658 (1986) (Pubitemid 17223467)
136. Tanapat P, N. B. Hastings, E. Gould: Ovarian steroids influence cell proliferation in the dentate gyrus of the adult female rat in a dose-and time-dependent manner. J Comp Neurol 481, 252-265 (2005) (Pubitemid 40023535)
137. Gould E, P. Tanapat, T. Rydel, N. Hastings: Regulation of hippocampal neurogenesis in adulthood. Biol Psychiatry 48, 715-20 (2000)
138. Leuner B, E. Gould, T. J. Shors: Is there a link between adult neurogenesis and learning? Hippocampus 16, 216-224 (2006)
139. Toran-Allerand C. D, L. Ellis, K. H. Pfenninger: Estrogen and insulin synergism in neurite growth enhancement in vitro: mediation of steroid effects by interactions with growth factors? Brain Res 469, 87-100 (1988)
140. Ferreira A, A. Caceres: Estrogen-enhanced neurite growth: evidence for a selective induction of Tau and stable microtubules. J Neurosci 11, 392-400 (1991)
141. Diaz H. A. Lorenzo, H. F.Carrer, A. Caceres: Time lapse study of neurite growth in hypothalamic dissociated neurons in culture: sex differences and estrogen. J Neurosci. Res 33, 266-281 (1992)
142. Brinton R. D, J. Tran, P. Proffitt, M. Montoya. 17 beta-Estradiol enhances the outgrowth and survival of neocortical neurons in culture. Neurochem Res 22, 1339-1351 (1997) (Pubitemid 27461133)
143. Masliah E, M. Mallory, N. Ge, M. Alford, I. Veinbergs, A. D. Roses: Neurodegeneration in the central nervous system of apoE-deficient mice. Exp Neurol 136, 107-122. 1995)
144. Anderson R, J. C. Barnes, T. V. Bliss, D. P. Cain, K. Cambon, H. A. Davies, M. L. Errington, L. A. Fellows, R. A. Gray, T. Hoh, M. Stewart, C. H. Large, G. A. Higgins: Behavioural, physiological and morphological analysis of a line of apolipoprotein E knockout mouse. Neuroscience 85, 93-110 (1998) (Pubitemid 28228418)
145. Laskowitz D. T, K. Horsburgh, A. D. Roses: Apolipoprotein E and the CNS response to injury. J Cereb Blood Flow Metab 18, 465-471 (1998) (Pubitemid 28213530)
146. Sheng J. G, R. A. Jones, X. Q. Zhou, J. M. McGinness, L. J. Van Eldik, R. E. Mrak, W. S. Griffin: Interleukin-1 promotion of MAPK-p38 overexpression in experimental animals and in Alzheimer's disease: potential significance for tau protein phosphorylation. Neurochem Int 39, 341-348 (2001) (Pubitemid 32907398)
147. McColl B. W, A. L. McGregor, A. Wong, J. D. Harris, A. Amalfitano, S. Magnoni, A. H. Baker, G. Dickson, K. Horsburgh: APOE epsilon3 gene transfer attenuates brain damage after experimental stroke. J Cereb Blood Flow Metab 27, 477-487 (2007)
148. Mori T, T. Town, M. Kobayashi, J. Tan, S. C. Fujita, T. Asano: Augmented delayed infarct expansion and reactive astrocytosis after permanent focal ischemia in apolipoprotein E4 knock-in mice. J Cereb Blood Flow Metab 24, 646-656 (2004) (Pubitemid 38725369)
149. Fagan A. M, B. A. Murphy, S. N. Patel, J. F. Kilbridge, W. C., Mobley, G Bu, D. M. Holtzman:. Evidence for normal aging of the septo-hippocampal cholinergic system in apoE (-/-) mice but impaired clearance of axonal degeneration products following injury. Exp Neurol 151, 314-325 (1998) (Pubitemid 28285911)
150. Kitagawa K, M. Matsumoto, K. Kuwabara, T. Ohtsuki, M. Hori: Delayed, but marked, expression of apolipoprotein E is involved in tissue clearance after cerebral infarction. J Cereb Blood Flow Metab 21, 1199-1207 (2001) (Pubitemid 32947486)
151. Herz J, U. Hamann, S. Rogne, O. Myklebost, H. Gausepohl, K. K. Stanley: Surface location and high affinity for calcium of a 500-kd liver membrane protein closely related to the LDL-receptor suggest a physiological role as lipoprotein receptor. EMBO J. 7, 4119-4127 (1988)
152. Kowal R. C, J. Herz, K. H. Weisgraber, R. W. Mahley, M. S. Brown, J. L. Goldstein: Opposing effects of apolipoproteins E and C on lipoprotein binding to low density lipoprotein receptor-related protein. J Biol Chem 265, 10771-10779 (1990)
153. Takahashi S. Y. Kawarabayasi, T. Nakai, J. Sakai, T. Yamamoto: Rabbit very low density lipoprotein receptor: a low density lipoprotein receptor-like protein with distinct ligand specificity. Proc Natl Acad Sci USA 89, 9252-9256 (1992)
154. Willnow T. E , J. L. Goldstein, K. Orth, M. S. Brown, J. Herz: Low density lipoprotein receptor-related protein and gp330 bind similar ligands, including plasminogen activator-inhibitor complexes and lactoferrin, an inhibitor of chylomicron remnant clearance J Biol Chem 267, 26172-26180 (1992) (Pubitemid 23014032)
155. Goodrum J. F, J. E. Weaver, N. D. Goines, T. W. Bouldin: Fatty acids from degenerating myelin lipids are conserved and reutilized for myelin synthesis during regeneration in peripheral nerve. J Neurochem 65, 1752-1759 (1995)
156. Poirier J, A. Baccichet, D. Dea, S. Gauthier: Cholesterol synthesis and lipoprotein reuptake during synaptic remodelling in hippocampus in adult rats. Neuroscience 55, 81-90 (1993) (Pubitemid 23194987)
157. Snipes G. J, C. B. McGuire, J. J. Norden, J. A. Freeman: Nerve injury stimulates the secretion of apolipoprotein E by nonneuronal cells. Proc Natl Acad Sci USA 83, 1130-1134 (1986) (Pubitemid 16086426)
158. Popko B, J. F. Goodrum, T. W. Bouldin, S. H. Zhang, N. Maeda: Nerve regeneration occurs in the absence of apolipoprotein E in mice. J Neurochem 60, 1155-1158 (1993) (Pubitemid 23066741)
159. Poirier J, M. Hess, P. C. May, C. E. Finch: Astrocytic apolipoprotein E mRNA and GFAP mRNA in hippocampus after entorhinal cortex lesioning. Brain Res Mol Brain Res 11, 97-106 (1991)
160. Nathan B. P, R. Nisar, S. Randall, J. Short, M. Sherrow, G. K. Wong, R. G. Struble: Apolipoprotein E is upregulated in olfactory bulb glia following peripheral receptor lesion in mice. Exp Neurol 172, 128-136 (2001) (Pubitemid 33141160)
161. Buttini M, H. Akeefe, C. Lin, R. W. Mahley, R. E. Pitas, T. Wyss-Coray, L. Mucke: Dominant negative effects of apolipoprotein E4 revealed in transgenic models of neurodegenerative disease. Neuroscience 97, 207-210 (2000) (Pubitemid 30224757)
162. Blain J. F, P. M. Sullivan, J. Poirier: A deficit in astroglial organization causes the impaired reactive sprouting in human apolipoprotein E4 targeted replacement mice. Neurobiol Dis 21, 505-514 (2006) (Pubitemid 43277533)
163. Krugers H. J, M. Mulder, J. Korf, L. Havekes, E. R. de Kloet, M. Joels: Altered synaptic plasticity in hippocampal CA1 area of apolipoprotein E deficient mice. Neuroreport 8, 2505-2510 (1997) (Pubitemid 27308451)
164. Veinbergs I, M. W. Jung, S. J. Young, E. Van Uden, P. M. Groves, E. Masliah: Altered long-term potentiation in the hippocampus of apolipoprotein E-deficient mice. Neurosci Lett 249, 71-77 (1998)
165. Choudhuri R, L. Cui, C. Yong, S. Bowyer, R. M. Klein, K. M. Welch, N. E. Berman: Cortical spreading depression and gene regulation: relevance to migraine. Ann Neurol 51, 499-506 (2002) (Pubitemid 34260780)
166. Kraig R. P, L. M. Dong, R. Thisted, C. B. Jaeger: Spreading depression increases immunohistochemical staining of glial fibrillary acidic protein. J Neurosci 11, 2187-2198 (1991)
167. Struble R. G, J. Short, M. Ghobrial, B. P. Nathan: Apolipoprotein E immunoreactivity in human and mouse olfactory bulb. Neurosci Lett. 267, 137-140 (1999) (Pubitemid 29251605)
168. Nathan B. P, S. Nannapaneni, S. Gairhe, I. Nwosu, R. G. Struble: The distribution of apolipoprotein E in mouse olfactory epithelium. Brain Res 1137, 78-83 (2007) (Pubitemid 46240053)
169. Nathan B. P, R. Nisar, J. Short, S. Randall, E. Grissom, G. Griffin, P. V. Switzer, R. G. Struble: Delayed olfactory nerve regeneration in ApoE-deficient mice. Brain Res 1041, 87-94 (2005) (Pubitemid 40445392)
170. Nathan B. P, S. Bellosta, D. A. Sanan, K. H. Weisgraber, R. W. Mahley, R. E. Pitas: Differential effects of apolipoproteins E3 and E4 on neuronal growth in vitro. Science 264, 850-852 (1994) (Pubitemid 24193454)
171. Nathan B. P, K. C. Chang, S. Bellosta, E. Brisch, N. Ge, R. W. Mahley, R. E. Pitas: The inhibitory effect of apolipoprotein E4 on neurite outgrowth is associated with microtubule depolymerization. J Biol Chem 270, 19791-19799 (1995)
172. Teter B, P. T. Xu, J. R. Gilbert, A. D. Roses, D. Galasko, G. M. Cole: Apolipoprotein E isoform-specific differences in neuronal sprouting in organotypic hippocampal culture. J Neurochem 73, 2613-2616 (1999)
173. Hayashi H, R. B. Campenot, D. E. Vance, J. E. Vance: Glial lipoproteins stimulate axon growth of central nervous system neurons in compartmented cultures. J Biol Chem 279, 14009-14015 (2004) (Pubitemid 38468935)
174. Nathan B. P, Y. Jiang, G. K. Wong, F. Shen, G. J. Brewer, R. G. Struble: Apolipoprotein E4 inhibits, and apolipoprotein E3 promotes neurite outgrowth in cultured adult mouse cortical neurons through the low-density lipoprotein receptor-related protein. Brain Res 928, 96-105 (2002) (Pubitemid 34159056)
175. Nathan B. P, A. G. Barsukova, F. Shen, M. McAsey, R. G. Struble: Estrogen facilitates neurite extension via apolipoprotein E in cultured adult mouse cortical neurons. Endocrinology 145, 3065-3073, (2004) (Pubitemid 38829971)
176. Colton C. A, D. L. Gilbert: Production of superoxide anions by a CNS macrophage, the microglia. FEBS Lett 223, 284-288 (1987)
177. Barger S. W, A. D. Harmon: Microglial activation by Alzheimer amyloid precursor protein and modulation by apolipoprotein E. Nature 388, 878-881 (1997) (Pubitemid 27377060)
178. Laskowitz D. T, A. D.Thekdi, S. D.Thekdi, S. K. Han, J. K. Myers, S. V.Pizzo, E. R Bennett: Downregulation of microglial activation by apolipoprotein E and apoE-mimetic peptides. Exp Neurol 167, 74-85 (2001) (Pubitemid 32093924)
179. Laskowitz D. T, W. D. Matthew, E. R. Bennett, D. Schmechel, M. H. Herbstreith, S. Goel, , M. K. McMillian: Endogenous apolipoprotein E suppresses LPS-stimulated microglial nitric oxide production. Neuroreport 9, 615-618 (1998) (Pubitemid 28131273)
180. Colton C. A, M. Czapiga, J. Snell-Callanan, O. N. Chernyshev, M. P. Vitek: Apolipoprotein E acts to increase nitric oxide production in macrophages by stimulating arginine transport. Biochim Biophys Acta 1535, 134-144 (2001) (Pubitemid 32112760)
181. Lynch J. R, J. A. Pineda, D. Morgan, L. Zhang, D. S. Warner, H Benveniste, D. T. Laskowitz: Apolipoprotein E affects the central nervous system response to injury and the development of cerebral edema. Ann Neurol 51, 113-117 (2002) (Pubitemid 34027983)
182. Colton C. A, C. M. Brown, M. Czapiga, M. P. Vitek: Apolipoprotein-E allele-specific regulation of nitric oxide production. Ann N Y Acad Sci 962, 212-225 (2002) (Pubitemid 34592314)
183. Lynch J. R, D. Morgan, J. Mance, W. D. Matthew, D. T. Laskowitz: Apolipoprotein E modulates glial activation and the endogenous central nervous system inflammatory response. J Neuroimmunol 114, 107-113 (2001) (Pubitemid 32184731)
184. Brown C. M, E. Wright, C. A. Colton, P. M.Sullivan, , D. T.Laskowitz, , M. P. Vitek: Apolipoprotein E isoform mediated regulation of nitric oxide release. Free Radic Biol Med 32, 1071-1075 (2002) (Pubitemid 34603344)
185. Brown C. M., E. Wright, C. A. Colton, P. M.Sullivan, D. T. Laskowitz, M. P. Vitek: Apolipoprotein E isoform mediated regulation of nitric oxide release. Free Radic Biol Med 32, 1071-1075 (2002) (Pubitemid 34603344)
186. Czapiga M, C. A. Colton: Microglial function in human APOE3 and APOE4 transgenic mice: altered arginine transport. J Neuroimmunol 134, 44-51 (2003) (Pubitemid 36050829)
187. Colton C. A, C. M. Brown, D. Cook, L. K. Needham, Q. Xu, M. Czapiga, A. M. Saunders, D. E. Schmechel, K. Rasheed, M. P. Vitek: APOE and the regulation of microglial nitric oxide production: a link between genetic risk and oxidative stress. Neurobiol Aging 23, 777-785 (2002) (Pubitemid 35217702)
188. Colton C. A, C. M. Brown, M. P. Vitek: Sex steroids, APOE genotype and the innate immune system. Neurobiol Aging 26, 363-372. (2005) (Pubitemid 40082720)
189. Colton C. A, L. K. Needham, C. Brown, D. Cook K. Rasheed J. R. Burke, W. J. Strittmatter, D. E. Schmechel, M. P. Vitek: APOE genotype-specific differences in human and mouse macrophage nitric oxide production. J Neuroimmunol 147, 62-67 (2004) (Pubitemid 38114948)
190. Tiwari-Woodruff S, L. B. Morales, R. Lee, R. R. Voskuhl: Differential neuroprotective and antiinflammatory effects of estrogen receptor (ER)alpha and ERbeta ligand treatment. Proc Natl Acad Sci U S A 104, 14813-14818. (2007) (Pubitemid 350003225)
191. Krathwohl M. D, J. L. Kaiser. Chemokines promote quiescence and survival of human neural progenitor cells. Stem Cells 22, 109-118. (2004) (Pubitemid 38018787)
192. Caruso A, M. Motolese, L. Iacovelli, F. Caraci, A. Copani, F. Nicoletti, G. C. Terstappen, G. Gaviraghi, A. Caricasole: Inhibition of the canonical Wnt signaling pathway by apolipoprotein E4 in PC12 cells. J Neurochem 98, 364-371 (2006) (Pubitemid 44133142)
193. Levi O, D. M. Michaelson: Environmental enrichment stimulates neurogenesis in apolipoprotein E3 and neuronal apoptosis in apolipoprotein E4 transgenic mice. J Neurochem 100, 202-210 (2007) (Pubitemid 46085849)
194. Nilsen J, R. D. Brinton: Divergent impact of progesterone and medroxyprogesterone acetate (Provera) on nuclear mitogen-activated protein kinase signaling. Proc Natl Acad Sci U S A 100, 10506-10511 (2003) (Pubitemid 37071908)
195. Wang J. M, R. W. Irwin, R. D. Brinton: Activation of estrogen receptor alpha increases and estrogen receptor beta decreases apolipoprotein E expression in hippocampus in vitro and in vivo. Proc Natl Acad Sci U S A 103, 16983-16988 (2006) (Pubitemid 44737364)
196. Stone D. J, I. Rozovsky, T. E. Morgan, C. P. Anderson, H. Hajian, C. E. Finch: Astrocytes and microglia respond to estrogen with increased apoE mRNA in vivo and in vitro. Exp Neurol 143, 313-318 (1997) (Pubitemid 27148235)
197. Garcia-Estrada J, J. A. Del Rio, S. Luquin, E. Soriano, L. M. Garcia-Segura: Gonadal hormones downregulate reactive gliosis and astrocyte proliferation after a penetrating brain injury. Brain Res 628, 271-278 (1993) (Pubitemid 23331618)
198. Struble R. G, S. Afridi, S. Beckman-Randall, M. Li, C. Cady, B. Nathan, M. E. McAsey: Neocortical and hippocampal glial fibrillary acidic protein immunoreactivity shows region-specific variation during the mouse estrous cycle. Neuroendocrinology 83, 325-335 (2006) (Pubitemid 44729790)
199. Shughrue P. J, M. V. Lane, I. Merchenthaler: Comparative distribution of estrogen receptor-alpha and-beta mRNA in the rat central nervous system. J Comp Neurol 388, 507-25 (1997) (Pubitemid 27481288)
200. Shughrue P. J, I. Merchenthaler: Evidence for novel estrogen binding sites in the rat hippocampus. Neuroscience 99, 605-612. 2000)
201. Pitas R. E, J. K. Boyles, S. H. Lee, D. Foss, R. W. Mahley: Astrocytes synthesize apolipoprotein E and metabolize apolipoprotein E-containing lipoproteins. Biochim Biophys Acta 917, 48-61 (1987)
202. Boyles J. K, R. E .Pitas, E. Wilson, R. W. Mahley, J. M. Taylor: Apolipoprotein E associated with astrocytic glia of the central nervous system and with nonmyelinating glia of the peripheral nervous system. J Clin. Invest 76, 1501-1513 (1985) (Pubitemid 16193568)
203. Stone D. J, Y. Song, C. P. Anderson, K. K. Krohn, C. E. Finch, I. Rozovsky: Bidirectional transcription regulation of glial fibrillary acidic protein by estradiol in vivo and in vitro. Endocrinology 139, 3202-3209 (1998) (Pubitemid 28512350)
204. Araque A, G. Carmignoto, P. G. Haydon. Dynamic signaling between astrocytes and neurons. Ann Rev Physiol 63, 795-813 (2001) (Pubitemid 32304337)
205. Garcia-Segura L. M, M. M. McCarthy. Role of glia in neuroendocrine function. Endocrinology 145, 1082-1086 (2004)
206. Struble R. G, B. P. Nathan, C. Cady, X. Cheng, M. McAsey: Estradiol regulation of astroglia and apolipoprotein E: An important role in neuronal regeneration. Exp Gerontol 42, 54-63 (2007) (Pubitemid 44937823)
207. Schurr A, J. J. Miller, R. S. Payne, B. M. Rigor: An increase in lactate output by brain tissue serves to meet the energy needs of glutamate-activated neurons. J Neurosci 19, 34-39 (1999) (Pubitemid 29028946)
208. Kasischke K. A, H. D. Vishwasrao, P. J. Fisher, W. R. Zipfel, W. W. Webb: Neural activity triggers neuronal oxidative metabolism followed by astrocytic glycolysis. Science 305, 99-103 (2004) (Pubitemid 38869381)
209. Danbolt N. C: The high affinity uptake system for excitatory amino acids in the brain. Prog Neurobiol 44, 377-396. 1994) (Pubitemid 24337092)
210. Hertz L, R. Dringen, A. Schousboe, S. R. Robinson: Astrocytes: glutamate producers for neurons. J Neurosci Res 57, 417-428 (1999) (Pubitemid 29372916)
211. Schousboe A, N. Westergaard, L. Hertz: Neuronalastrocytic interactions in glutamate metabolism. Biochem Soc Trans 21, 49-53 (1993)
212. Pfrieger F. W, B. A. Barres: Synaptic efficacy enhanced by glial cells in vitro. Science 277, 1684-1687 (1997) (Pubitemid 27446234)
213. Mauch D H., K. Nagler, S. Schumacher, C. Goritz, E. C. Muller, A. Otto, F. W. Pfrieger: CNS synaptogenesis promoted by glia-derived cholesterol. Science 294, 1354-1357 (2001) (Pubitemid 33063104)
214. Ullian E. M, S. K. Sapperstein, . K. S.Christopherson, B. A Barres:. Control of synapse number by glia. Science 291, 657-661 (2001) (Pubitemid 32150425)
215. Inagaki M, Y. Gonda, K. Nishizawa, .S Kitamura, C. Sato, S. Ando, K. Tanabe, K. Kikuchi, S. Tsuiki, Y. Nishi: Phosphorylation sites linked to glial filament disassembly in vitro locate in a non-alpha-helical head domain. J Biol Chem 265, 4722-4729 (1990)
216. Kommers T, L. Vinade, C. Pereira, C. A. Goncalves, S. Wofchuk, R. Rodnight: Regulation of the phosphorylation of glial fibrillary acidic protein (GFAP) by glutamate and calcium ions in slices of immature rat spinal cord: comparison with immature hippocampus. Neurosci Lett 248, 141-143 (1998) (Pubitemid 28275953)
217. Matsutani S, N. Yamamoto: Neuronal regulation of astrocyte morphology in vitro is mediated by GABAergic signaling. Glia 20, 1-9 (1997) (Pubitemid 27207003)
218. Runquist M, G. Alonso: Gabaergic signaling mediates the morphological organization of astrocytes in the adult rat forebrain. Glia 41, 137-151 (2003) (Pubitemid 36262191)
219. Joels M: Steroid hormones and excitability in the mammalian brain. Front Neuroendocrinol 18, 2-48 (1997) (Pubitemid 27045164)
220. Kis Z, D. Budai, G. Imre, T. Farkas, S. Horvath, J. Toldi: The modulatory effect of estrogen on the neuronal activity in the barrel cortex of the rat. An electrophysiological study. Neuroreport 12, 2509-2512 (2001) (Pubitemid 32682212)
221. McEwen B: Estrogen actions throughout the brain. Recent Prog Horm Res 57, 357-384 (2002)
222. Rudick C. N, C. S. Woolley: Estrogen regulates functional inhibition of hippocampal CA1 pyramidal cells in the adult female rat. J Neurosci 21, 6532-6543 (2001) (Pubitemid 32781097)
223. Rudick C. N, R. B. Gibbs, C. S. Woolley: A role for the basal forebrain cholinergic system in estrogen-induced disinhibition of hippocampal pyramidal cells. J Neurosci 23, 4479-4490 (2003) (Pubitemid 36706178)